Covered recipient · General Payments record
JOSLYN GOBER
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation Pediatric Rehabilitation Medicine
General Payments · PY2018–2024
$1,415.14
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $435.68 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $265.99 | 11 |
| Genentech USA, Inc. | $76.17 | 3 |
| JAZZ PHARMACEUTICALS INC. | $38.35 | 1 |
| PFIZER INC. | $35.88 | 1 |
| ITF Therapeutics LLC | $19.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.03 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806352 | CMS |
| ABBVIE INC. | $26.44 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806354 | CMS |
| ABBVIE INC. | $26.22 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806356 | CMS |
| ABBVIE INC. | $28.02 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806358 | CMS |
| ABBVIE INC. | $21.50 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806360 | CMS |
| ABBVIE INC. | $27.10 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806362 | CMS |
| ABBVIE INC. | $23.37 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806364 | CMS |
| ABBVIE INC. | $27.71 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806366 | CMS |
| ABBVIE INC. | $21.81 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806368 | CMS |
| ABBVIE INC. | $24.73 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806370 | CMS |
| ABBVIE INC. | $13.06 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103806372 | CMS |
| Genentech USA, Inc. | $16.03 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133041653 | CMS |
| Genentech USA, Inc. | $26.23 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133041649 | CMS |
| Genentech USA, Inc. | $33.91 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133041657 | CMS |
| ITF Therapeutics LLC | $19.29 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082127563 | CMS |
| JAZZ PHARMACEUTICALS INC. | $38.35 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150198342 | CMS |
| PFIZER INC. | $35.88 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131298337 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.